Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$64.10 -0.69 (-1.06%)
As of: Oct 2, 2026 · 2:39 PM EDT

Arrowhead Pharmaceuticals (ARWR) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Arrowhead Pharmaceuticals (ARWR) recorded Depreciation & Amortization (CF) of $6.66 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 7.0% from $6.22 million a year earlier and up 4.6% from the prior quarter.

Analysis

Arrowhead Pharmaceuticals (ARWR) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

On a TTM basis, Arrowhead Pharmaceuticals' Depreciation & Amortization (CF) came in at $25.8 million as of Jun 30, 2026, up 14.3% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $23.93 million, up 28.7% from FY2024.

  • Annual Depreciation & Amortization (CF) has increased for six straight fiscal years, with a five-year compound annual growth rate of 32.1% (FY2020 to FY2025).
  • Across earlier fiscal years, Depreciation & Amortization (CF) came in at $18.6 million in FY2024 (+48.8%), $12.49 million in FY2023 (+19.9%), $10.42 million in FY2022 (+26.1%) and $8.27 million in FY2021 (+39.1%).
  • The fiscal Q3 2026 figure is the highest quarterly Depreciation & Amortization (CF) in data going back to fiscal Q4 2010.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased for 27 consecutive quarters, with growth averaging 22.3% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Depreciation & Amortization (CF) ranged from 2.9% (fiscal Q2 2023) to 69.5% (fiscal Q2 2024).
  • Per Business Quant, the preceding three fiscal quarters came in at $6.37 million (Q2 2026), $6.39 million (Q1 2026) and $6.39 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Arrowhead Pharmaceuticals 9.24 Bn 4.02 Bn - 6.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.66 Mn
Mar 31, 2026 6.37 Mn
Dec 31, 2025 6.39 Mn
Sep 30, 2025 6.39 Mn
Jun 30, 2025 6.22 Mn
Mar 31, 2025 6.08 Mn
Dec 31, 2024 5.24 Mn
Sep 30, 2024 5.03 Mn
Jun 30, 2024 4.78 Mn
Mar 31, 2024 4.53 Mn
Dec 31, 2023 4.26 Mn
Sep 30, 2023 3.86 Mn
Jun 30, 2023 3.28 Mn
Mar 31, 2023 2.67 Mn
Dec 31, 2022 2.69 Mn
Sep 30, 2022 2.66 Mn
Jun 30, 2022 2.59 Mn
Mar 31, 2022 2.59 Mn
Dec 31, 2021 2.57 Mn
Sep 30, 2021 2.50 Mn
API Access

Arrowhead Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ARWR&period=max&api_key=YOUR_API_KEY